Sponsor pipeline

Atossa Therapeutics, Inc. clinical trial pipeline

Get alerts when Atossa Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-10-09 NCT07869732 (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty Phase 2 Not Yet Recruiting

Active trials by phase

Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07869732 (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty Precocious Puberty, Gonadotropin-dependent Not Yet Recruiting 2026-10-09
NCT05607004 (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer Breast Neoplasms Active, Not Recruiting 2026-07-08

Disease areas by active trials

Breast Cancer (1)

Get alerts when Atossa Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free